 |
| Global Linear Accelerators For Radiation Market Growth |
The Global Linear Accelerators For Radiation Market Is Estimated To Be Valued At US$ 6.9 Bn In 2023 And Is Expected To Exhibit A CAGR Of 5.0% Over The Forecast Period 2023 To 2030, As Highlighted In A New Report Published By Coherent Market Insights.
Market Overview:
Linear Accelerators, Also Known As Linacs, Are Medical Devices That Use High Energy X-Rays To Treat Cancer In Patients. They Generate High-Energy X-Ray Beams To Damage The DNA Of Cancer Cells And Destroy Their Ability To Multiply. The Advent Of Advanced Technologies Like Volumetric Arc Therapy And Flattening Filter Free Accelerators Have Made The Treatment More Precise And Effective With Less Damage To Surrounding Healthy Tissues.
Market Key Trends:
One Of The Major Trends In The Linear Accelerators For Radiation Market Is The Rising Adoption Of Compact Linacs. The Size And Cost Of Conventional Linacs Have Restricted Their Use To Large Hospitals And Cancer Centers Only. However, New Compact Linac Models Are Small Enough To Fit Into The Limited Space Available In Many Clinics And Physician Offices. Their Simplified Design And Lower Price Make Cancer Treatment Using Linacs Accessible To More Patients. This Is Expected To Significantly Drive The Demand For Compact Linacs In The Forecast Period.
Segment Analysis
The Linear Accelerators For Radiation Market Is Dominated By The Medical Radiotherapy Segment. Over 70% Of The Linear Accelerators Are Used For External Beam Radiotherapy To Treat Cancer Patients. Radiotherapy Uses High-Energy Radiation To Shrink Tumors And Kill Cancer Cells And Is An Integral Part Of The Cancer Treatment Regimen. It Is One Of The Most Commonly Used Cancer Treatment Options Either Alone Or In Combination With Surgeries And Chemotherapy. Within Medical Radiotherapy, Linear Accelerators Find The Largest Application In Breast Cancer And Lung Cancer Treatments Due To The High Prevalence Of These Cancers Worldwide.
Key Takeaways
The Global Linear Accelerators For Radiation Market Growth Is Expected To Witness High Growth, Exhibiting A CAGR Of 5.0% Over The Forecast Period, Due To Increasing Prevalence Of Cancer Worldwide. Cancer Cases Have Been Rising Rapidly Owing To Changing Lifestyle Patterns, Rising Urbanization, And Increasing Risk Factors Such As Tobacco Consumption And Obesity. According To WHO, Cancer Burden Is Expected To Grow To 27.5 Million New Cancer Cases And 16.3 Million Cancer Deaths By 2040.
Regional Analysis
North America Dominated The Market In 2023, Accounting For Over 30% Of The Global Revenue, Due To Higher Adoption Of Advanced Cancer Treatment Options And Large Presence Of Leading Linear Accelerator Manufacturers. Asia Pacific Is Poised To Be The Fastest-Growing Region, Advancing At A CAGR Of 6.0% During The Forecast Period. This Can Be Attributed To Growing Healthcare Infrastructure, Rising Disposable Income, Rapidly Aging Population, And Increasing Cancer Awareness In Emerging Economies Of China And India.
Key Players
Key Players Operating In The Linear Accelerators For Radiation Market Are Huiheng Medical Inc., Top Grade Healthcare, Varian Medical Systems, Accuray Inc., Hitachi, Shinva Medical Instrument Co. Ltd., And Elekta AB. Varian Medical Systems And Elekta AB Collectively Hold Over 50% Of The Market Share Owing To Their Vast Product Portfolio And Extensive Global Distribution Network.
Get
More Insights On This Topic: https://www.pressreleasebulletin.com/global-linear-accelerators-for-radiation-market-growth/